Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Income towards Parent Company: 2013-2018

Historic Income towards Parent Company for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$1.1 million.

  • Armata Pharmaceuticals' Income towards Parent Company rose 53.19% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$15.9 million, marking a year-over-year decrease of 63.16%. This contributed to the annual value of -$53.2 million for FY2024, which is 22.71% down from last year.
  • As of Q4 2018, Armata Pharmaceuticals' Income towards Parent Company stood at -$1.1 million, which was up 60.27% from -$2.8 million recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year Income towards Parent Company high stood at -$779,000 for Q3 2017, and its period low was -$11.3 million during Q1 2014.
  • Over the past 3 years, Armata Pharmaceuticals' median Income towards Parent Company value was -$3.1 million (recorded in 2016), while the average stood at -$3.9 million.
  • Per our database at Business Quant, Armata Pharmaceuticals' Income towards Parent Company tumbled by 691.25% in 2014 and then spiked by 76.61% in 2017.
  • Over the past 5 years, Armata Pharmaceuticals' Income towards Parent Company (Quarterly) stood at -$2.6 million in 2014, then fell by 10.40% to -$2.9 million in 2015, then slumped by 250.75% to -$10.1 million in 2016, then surged by 76.61% to -$2.4 million in 2017, then skyrocketed by 53.19% to -$1.1 million in 2018.
  • Its Income towards Parent Company stands at -$1.1 million for Q4 2018, versus -$2.8 million for Q3 2018 and -$9.7 million for Q2 2018.